TCF7L2 - Tcf7l2 transcription factor 7 like 2 Gene
Species: Rattus norvegicus
Summary
Predicted to enable several functions, including DNA-binding transcription activator activity, RNA polymerase II-specific; armadillo repeat domain binding activity; and beta-catenin binding activity. Involved in negative regulation of apoptotic process and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin; cytosol; and nucleoplasm. Predicted to be part of beta-catenin-TCF7L2 complex and protein-DNA complex. Biomarker of type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in colorectal cancer; diabetes mellitus (multiple); pancreatic cancer; and prostate Cancer. Orthologous to human TCF7L2 (transcription factor 7 like 2). [provided by Alliance of Genome Resources, Apr 2022]
TCF7L2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001191052.2 | NP_001177981.1 | transcription factor 7-like 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables promoter-specific chromatin binding |
IDA
IDA: Inferred from direct assay
|
21901280 | RGD |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in negative regulation of extrinsic apoptotic signaling pathway |
IMP
IMP: Inferred from mutant phenotype
|
21965303 | RGD |
| involved in negative regulation of gluconeogenesis |
IMP
IMP: Inferred from mutant phenotype
|
21901280 | RGD |
| involved in negative regulation of transcription by RNA polymerase II |
IMP
IMP: Inferred from mutant phenotype
|
21901280 | RGD |
| involved in negative regulation of type B pancreatic cell apoptotic process |
IMP
IMP: Inferred from mutant phenotype
|
21965303 | RGD |
| involved in positive regulation of transcription by RNA polymerase II |
IMP
IMP: Inferred from mutant phenotype
|
21965303 | RGD |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
transcription factor 7-like 2 |
|